Advancements in Drug-Coated Balloons for CTO PCI

Created using ChatSlide

This study by Euro CTO Investigators, led by Niccolò Ciardetti, analyses Drug-Coated Balloons (DCBs) in Complex Total Occlusions (CTO) through the ERCTO registry from 2016 to 2023. Aiming to assess DCB efficacy in CTO Percutaneous Coronary Intervention (PCI), it examined 40,449 cases across 184 centres. Results show significant DCB adoption, rising from 3.4% to 14.9%, offering advantages like reduced stent usage and increased safety by decreasing pericardial tamponade risks. The study...